Financial Performance - The company incurred net losses of approximately $288.7 million, $279.7 million, and $268.8 million for the fiscal years ended April 30, 2025, 2024, and 2023 respectively, resulting in an accumulated deficit of $1.4 billion as of April 30, 2025[174]. - The company expects to continue incurring net losses for the foreseeable future due to substantial investments in customer acquisition and software development[174]. - Increased compliance costs and operational expenses may negatively affect future results if revenue does not increase sufficiently[175]. - Revenue metrics such as net dollar-based retention rate may not accurately indicate future financial results due to dependence on a small number of high-value customer contracts[196]. - A decline in new or renewed subscriptions may have a small immediate impact but will negatively affect future revenue[229]. - The company may require additional financing in the future, which could lead to substantial dilution for existing stockholders if equity is sold[266]. - The company has limited experience in acquisitions and may face challenges in finding suitable candidates or integrating acquired businesses effectively[267]. Revenue and Customer Dynamics - Revenue growth may be adversely impacted by factors such as reduced demand for C3 AI Software, increased competition, and the inability to accurately forecast demand[176]. - A limited number of customers have historically accounted for a substantial portion of revenue, and if these customers do not renew contracts, revenue could decline[177]. - The average total subscription contract value is decreasing as the company expands its customer base beyond a small number of large customers[177]. - Future success depends on the ability to sell additional subscriptions to existing customers and ensure their renewal upon contract expiration[181]. - The company intends to grow its customer base by introducing product offerings with a lower entry price point, but faces risks associated with supporting smaller customers[182]. - The company derives substantially all of its revenue from subscriptions to C3 AI Software and Center of Excellence support services, making market acceptance critical for continued success[184]. - Future revenue growth depends on the ability to establish and maintain successful strategic partner relationships, which requires significant time and resources[202]. Competition and Market Risks - The company faces intense competition from various sources, including larger competitors with broader offerings and innovative startups[187]. - Changes in subscription or pricing models may adversely affect operating results, especially as new competitors enter the market[197]. - The introduction of new AI platforms by competitors could render C3 AI Software obsolete, adversely affecting business and financial condition[210]. - The market for C3 AI Software may not grow as expected, impacting business and financial condition if businesses fail to adopt the software[205]. Operational Challenges - The sales cycles for C3 AI Software can be long and unpredictable, particularly for large subscriptions, which may extend over several years[194]. - Individual large sales can represent a significant portion of overall sales, impacting cash flow and margins, making it difficult to project revenue accurately[195]. - Rapid growth since 2009 has placed significant strain on management and operational resources, which may affect future growth planning[217]. - Recruiting and training qualified sales representatives is resource-intensive, and delays in this process could hinder sales operations[213]. - Marketing and sales efforts must generate significant revenue increases; otherwise, sales growth may be slower than anticipated[214]. Compliance and Regulatory Risks - Compliance with evolving data privacy laws, such as GDPR and CCPA, imposes significant obligations and potential fines for noncompliance[236][240]. - The inability to lawfully transfer personal data across borders may lead to operational disruptions and increased regulatory scrutiny[238]. - The company faces increased compliance costs and potential liabilities due to stringent data protection laws in various jurisdictions[239]. - Future changes in data privacy regulations may require significant adaptations in business practices and contractual arrangements[239]. - The EU AI Act, effective from August 1, 2024, could impose fines of up to €35 million or 7% of the company's total worldwide annual turnover for non-compliance[241]. Cybersecurity and Data Protection - Cybersecurity threats, including ransomware and denial-of-service attacks, are increasing and could disrupt business operations and lead to reputational harm[245]. - The costs associated with responding to a security breach could be significant, potentially leading to unexpected interruptions and negative publicity[248]. - The company may face increased compliance burdens and costs due to rapidly evolving laws and regulations regarding data privacy and security[248]. - The company’s C3 AI Software processes sensitive data, and any security incidents could result in significant legal and financial consequences[244]. Intellectual Property and Legal Risks - The company holds a patent portfolio with 35 issued patents in the U.S. and over 60 pending applications, indicating a strong focus on intellectual property protection[297]. - The company may incur substantial indemnity payments due to intellectual property infringement claims, which could harm its financial results[296]. - The company faces potential legal risks related to the use of third-party open source software, which could lead to significant legal expenses and damages[298]. - The enforceability of the Apache License, Version 2.0, under which components of the C3 AI Software are provided, could negatively impact the company's software development and licensing model[302]. Market and Stock Performance - The trading price of the company's Class A common stock has been volatile, influenced by various factors including market fluctuations and sales by stockholders[304]. - The dual class structure of the company's common stock concentrates voting control with Class B stockholders, limiting the influence of Class A stockholders on corporate matters[309]. - Substantial future sales of Class A and Class B common stock could depress the market price of Class A common stock[312]. - The company may not be included in certain stock indices due to its dual class capital structure, potentially affecting its attractiveness to investors[311]. Foreign Operations and Currency Risks - The company is exposed to risks associated with fluctuations in foreign currency exchange rates as it expands international operations[258]. - 6% of revenue for the fiscal years ended April 30, 2025 and 2024 were denominated in currencies other than U.S. dollars[258]. - 7% of expenses for the fiscal years ended April 30, 2025 and 2024 were denominated in currencies other than U.S. dollars[258]. - A hypothetical 10% change in foreign currency exchange rates may result in a material impact on consolidated financial statements[465]. Miscellaneous Risks - Legal proceedings may arise that could negatively impact the company's business and financial condition[328]. - Catastrophic events could disrupt the company's operations, particularly given its location in a seismically active region[329]. - The company is subject to significant legal, accounting, and compliance costs as a public company, which may impact its financial condition[321].

Phase 1 clinical study of TERN-601 demonstrated differentiated profile in 28-day study; topline data were presented in September 2024 Phase 2 FALCON clinical trial of TERN-601 completed enrollment; 12-week data expected in 4Q 2025 FOSTER CITY, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and ...

Table of Contents | UNITED STATES | | | --- | --- | | SECURITIES AND EXCHANGE COMMISSION | | | Washington, D.C. 20549 | | | FORM 10-Q | | | (MARK ONE) | | | ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF | | | 1934 | | | For the quarterly period ended March 31, 2025 | | | ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF | | | 1934 | | | For the transition period from | to | | Commission File Number: 001-42636 | | | EGH ACQUISITION CO ...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Digimarc Corporation (NASDAQ: DMRC) between May 3, 2024 and February 26, 2025, both dates inclusive (the “Class Period”), of the important July 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased Digimarc securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH ...

STAMFORD, Conn., June 23, 2025 (GLOBE NEWSWIRE) -- With summer travel season in full swing, KAYAK has released new insights to help travelers avoid one of the most frustrating parts of flying: delays. Drawing from summer flight data last year, KAYAK's latest analysis pinpoints the most delay-prone times during the day, worst days and busiest airports – plus expert tips on how to fly smarter right now. Key Findings: JFK (New York), CLT (Charlotte), and MIA (Miami) reported the highest percentage of delays am ...

上市公司名称：亚振家居股份有限公司 登录新浪财经APP 搜索【信披】查看更多考评等级 注册地址：江苏省南通市如东县曹埠镇亚振桥 办公地址：江苏省南通市如东县曹埠镇亚振桥 股票上市地点：上海证券交易所 联系人：黄周斌 联系电话：0513-84296002 收购人名称：吴涛 通讯地址：济南市历城区**** 独立财务顾问名称：民生证券股份有限公司 股票简称：*ST亚振 股票代码：603389 董事会报告书签署日期：二〇二五年六月 有关各方及联系方式 上市公司名称：亚振家居股份有限公司 联系地址：江苏省南通市如东县曹埠镇亚振桥 联系地址：中国（上海）自由贸易试验区浦明路8号 联系人：赵勇、丁小园 联系电话：021-80508627 董事会声明 一、本公司全体董事确信本报告不存在任何虚假记载、误导性陈述或重大遗漏，并对其内容的真实性、 准确性、完整性负个别的和连带的责任； 二、本公司全体董事已履行诚信义务，向股东所提出的建议是基于公司和全体股东的整体利益客观审慎 做出的； 三、本公司全体董事没有任何与本次收购相关的利益冲突。 释义 本报告书中，除非另有说明，下列简称具有如下特定意义： ■ 注：本报告书中部分合计数与各分 ...

证券代码：600018 证券简称：上港集团 公告编号：临2025-028 上海国际港务（集团）股份有限公司 第三届董事会第五十六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 上海国际港务（集团）股份有限公司（以下简称："上港集团"或"公司"）第三届董事会第五十六次会议 于2025年6月23日以通讯方式召开。会议通知和材料已于2025年6月13日以书面、电子邮件等方式发出， 会议应参加表决董事11名，实际参加表决董事11名。公司监事、董事会秘书、总审计师列席了会议，会 议符合《公司法》、《公司章程》及相关法律、法规的要求。会议经全体董事认真审议，一致通过以下 议案： 一、审议通过了《关于上港物流为下属全资子公司上港保税出具担保函的议案》。 董事会同意根据上海国际能源交易中心股份有限公司（以下简称："能源中心"）相关规定，由上港集团 全资子公司上港集团物流有限公司（以下简称："上港物流"）为其下属全资子公司上海上港保税仓储管 理有限公司（以下简称："上港保税"）向能源中心申请指定期货交割库（国际铜期货库容1万吨） ...

与每年1月在瑞士达沃斯小镇召开的世界经济论坛年会不同，夏季达沃斯更加聚焦商业未来和技术进 步。 从议程设置到企业展区，与AI相关的讨论和应用展示占据显著位置。在会场展区内，天工机器人、脑 机交互设备、全自动无人机巡检系统等AI产品吸引了大量参会者驻足观看。 全球经济形势正在发生剧烈变化。今年首期世界经济论坛《首席经济学家展望》报告指出，全球经济将 在2025年面临重大挑战，56%的受访首席经济学家预计经济会走弱。虽然全球大多数地区的通胀正在放 缓，但不确定性仍然较高，地区之间增长差异正在形成。 世界经济论坛第十六届新领军者年会（以下简称"2025夏季达沃斯"）即将拉开帷幕，证券时报记者第一 时间探访年会现场，捕捉2025夏季达沃斯的亮点。作为观察全球经济脉动和产业变革浪潮的重要窗口， 本届夏季达沃斯论坛参会人数创近年之最，充分彰显年会的影响力和中国超大规模市场的吸引力。 "这是我第二次参会，我个人最关注的话题是科技，特别是与人工智能（AI）相关的。"在夏季达沃斯开 幕前一日，证券时报记者在现场采访了图灵新智算创始人刘淼，他分享了对本届夏季达沃斯的前瞻观 察。 正如刘淼所言，AI已成为本届夏季达沃斯论坛的核心议 ...

哈梅内伊强调伊朗不会屈服于侵略 智通财经6月24日电，据CCTV国际时讯，当地时间6月23日晚，北京时间今天（6月24日）凌晨，在伊 朗对卡塔尔境内驻有美军的乌代德空军基地发动报复性导弹袭击后，伊朗最高领袖哈梅内伊的社媒账号 发帖，内容为："我们未曾侵略他人，也绝不接受任何人的侵略，更不会屈服于任何人的侵略。这就是 伊朗民族的逻辑。 ...

Hims & Hers Health ((HIMS) has been one of the market’s standout growth stocks in recent years. The company has successfully built a direct-to-consumer health platform targeting conditions like hair loss, mental health, and more recently, weight loss—delivering very strong revenue growth and stock returns.Shares had soared more than 150% (on two separate occasions) through the first half of 2025 before crashing more than 30% on Monday following a major partnership setback.The selloff was triggered by news t ...